Lauxera Capital Partners is an independent, international, healthcare-focused asset management company. Our growth equity investments focus primarily on commercial-stage medical devices, digital health, life sciences tools, and healthcare data companies.
Led by entrepreneurial company builders and seasoned healthcare investors with experience across international markets, we empower European healthtech entrepreneurs to deliver the growth promised by their innovations.
Lauxera was created in 2020 and has offices in Paris and San Francisco.
Led by entrepreneurial company builders and seasoned healthcare investors with experience across international markets, we empower European healthtech entrepreneurs to deliver the growth promised by their innovations.
Lauxera was created in 2020 and has offices in Paris and San Francisco.
Location: France, Ile-de-France
Employees: 11-50
Founded date: 2020
Portfolio 10
| Date | Name | Website | Total Raised | Location |
| 20.08.2026 | BRIDGE TO ... | bridgetolife.com | $110M | United Sta... |
| 12.09.2023 | BioLamina | biolamina.com | $18.28M | Sweden, Su... |
| 29.09.2022 | Veranex So... | veranexsolutions.com | - | United Sta... |
| 15.09.2022 | VERDOT Ips... | verdotips2.com | - | France |
| 16.06.2022 | Matrix Req... | matrixreq.com | $10.53M | Germany, B... |
| 30.05.2022 | Reapplix | reapplix.com | $3.03M | Denmark, B... |
| - | Lifen | lifen.fr | $80.7M | France, Il... |
| - | Groupe PSI... | groupepsih.com | - | France, Au... |
| - | Caresyntax | caresyntax.com | $453.8M | United Sta... |
| - | LUMICKS | lumicks.com | $93.03M | United Sta... |
Persons 22
| Date | First Name | Last Name | Title | Location | |||
| - | Victor | Decrion | Partner | - | - | - | |
| - | Pierre | Moustial | Founding P... | - | - | - | |
| - | Lise | de Courvil... | Head of In... | - | - | - | |
| - | Anaïs | Raevel | Analyst | - | - | - | |
| - | Alexia | Renaut | Associate | - | - | - | |
| - | Pauline | Ritter | Principal | - | - | - | |
| - | Charles | Cornevin | Principal | - | - | - | |
| - | Nicolas | Paulmier | Senior Inv... | - | - | - | |
| - | Elsy | Boglioli | Senior Adv... | - | - | - | |
| - | Alessandra | Malaval | Senior Ass... | - | - | - |
Show more
News 17
Show more
Mentions in press and media 15
| Date | Title | Description |
| 25.08.2026 | Bridge to Life Secures $110 Million for Organ Transplant Innovation. VitaSmart Drives Commercial Surge. | Bridge to Life secured $110 million in Series C equity and debt financing. This significant capital influx will accelerate the nationwide commercialization of VitaSmart, its FDA-cleared hypothermic oxygenated perfusion system for liver tran... |
| 20.08.2026 | Bridge To Life Raises $110 Million To Scale FDA-Cleared VitaSmart Liver Perfusion System And Expand Organ Transplant Pipeline | Bridge to Life has completed $110 million in Series C equity and debt financing to accelerate the U.S. commercialization of its VitaSmart Hypothermic Oxygenated Perfusion System and advance a broader pipeline of organ preservation and viabi... |
| 24.02.2025 | OrganOx Closes $142M Equity Financing | OrganOx, an Oxford, UK-based organ medical technology company, raised $142M in equity funding. The round was led by new investor HealthQuest Capital with participation from existing investors BGF and Lauxera Capital Partners, along with add... |
| 12.09.2023 | Lauxera Capital Partners invests €17 million in Swedish regenerative medicine leader BioLamina AB | - |
| 17.07.2023 | UK Startup OrganOx Secures $32.6M for Liver Transplantation Device | What You Should Know: – OrganOx, a United Kingdom-based medical technology company committed to making every donated organ count with metra®, a fully automated normothermic machine perfusion (NMP) device for liver transplantation raises £25... |
| 17.07.2023 | Lauxera Capital Partners has led a £25m growth investment into OrganOx | - |
| 17.07.2023 | Oxford’s OrganOx raises a £25 million profusion to expand its commercial footprint and make transplant organs more widely available | Oxford-based medtech firm OrganOx has raised £25 million in growth investment as it looks to expand its commercial footprint. The company was founded in Oxford, as a spin out of the university, in 2008 – it says this growth funding is a ste... |
| 16.06.2022 | Lauxera Capital Partners invests €10m in German Medtech software company Matrix Requirements | - |
| 09.02.2022 | Paris-based Lauxera Capital Partners sets high stakes on health tech with $300 million maiden fund | Investment firm based in Paris and San Francisco, Lauxera Capital Partners announced the final closing of its first fund, Lauxera Growth I, at more than €260 million (approximately $300 million), making it one of the leading European funds ... |
| 16.11.2021 | Leading MedTech Lifen raises € 50M to bring healthcare systems into the digital age | Lifen, one of the leading HealthTech startups in France, announces a 50 million euro Series C financing led by Creadev and Lauxera Capital Partners, in which the previous investors Serena and Partech are also participating. Lifen will use ... |
Show more